Related Experiment Video
Updated: Nov 17, 2025

Phage Phenomics: Physiological Approaches to Characterize Novel Viral Proteins
Published on: June 11, 2015
Complete Genome Sequence of Burkholderia cenocepacia Phage Mica
James Garcia1, Guichun Yao1, Maria Guadalupe Vizoso-Pinto2
1Center for Phage Technology, Texas A&M University, College Station, Texas, USA.
Abstract:
Burkholderia cenocepacia is a multidrug-resistant Gram-negative pathogen known to colonize patients with chronic granulomatous disease and cystic fibrosis. Here, we describe Burkholderia phage Mica, which is predicted to be a lysogenic myophage based on the similarity of its structural proteins to Enterobacteria phage P2 and Burkholderia phage KL3.
Insights
We identified Burkholderia phage Mica, a novel myophage targeting the multidrug-resistant pathogen Burkholderia cenocepacia. This discovery offers potential new avenues for combating infections in cystic fibrosis and chronic granulomatous disease patients.
Area of Science:
- Microbiology
- Virology
- Genomics
Background:
- * Burkholderia cenocepacia is a multidrug-resistant Gram-negative bacterium.
- * This pathogen frequently colonizes patients with chronic granulomatous disease and cystic fibrosis, leading to severe respiratory infections.
- * Effective therapeutic options are limited due to high levels of antimicrobial resistance.
Purpose of the Study:
- * To characterize a newly discovered bacteriophage, designated Burkholderia phage Mica.
- * To investigate the potential of Burkholderia phage Mica as a therapeutic agent against Burkholderia cenocepacia infections.
Main Methods:
- * Genomic analysis of Burkholderia phage Mica.
- * Comparative analysis of phage structural proteins with known myophages.
- * Prediction of the phage's life cycle (lysogenic or lytic).
Main Results:
- * Burkholderia phage Mica was identified and characterized.
- * Structural protein analysis suggests Mica is a myophage.
- * Based on sequence similarity to Enterobacteria phage P2 and Burkholderia phage KL3, Mica is predicted to be a lysogenic myophage.
Conclusions:
- * Burkholderia phage Mica represents a novel phage with potential for targeting Burkholderia cenocepacia.
- * Its predicted lysogenic nature warrants further investigation for phage therapy applications.
- * This finding contributes to the growing field of phage biocontrol for multidrug-resistant bacteria.
Related Concept Videos
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Bacterial Phylum Tenericutes
Viral Replication: Lytic Cycle

